| Application number | Title of the application | Filing Date | Status |
|---|
| 10/019580 | Induction of immune tolerance | Jun 5, 2002 | Abandoned |
Array
(
[id] => 6519160
[patent_doc_number] => 20020192210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Dendritic cell-specific antibodies'
[patent_app_type] => new
[patent_app_number] => 10/161298
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161298 | Dendritic cell-specific antibodies | Jun 2, 2002 | Abandoned |
| 10/018094 | Use of soluble protein molecules expressed by the pancreas and kidney glomerulus | May 19, 2002 | Abandoned |
Array
(
[id] => 6745066
[patent_doc_number] => 20030022249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Antigen-binding fragments that recognize a subset of dendritic cells and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/150440
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23925
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150440 | Antigen-binding fragments that recognize a subset of dendritic cells and methods of use thereof | May 16, 2002 | Abandoned |
Array
(
[id] => 6641627
[patent_doc_number] => 20030103897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods of using labelled verotoxin B subunit'
[patent_app_type] => new
[patent_app_number] => 10/147338
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7278
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147338 | Methods of using labelled verotoxin B subunit | May 14, 2002 | Abandoned |
Array
(
[id] => 7121981
[patent_doc_number] => 20050013810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Regulating immune response using dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 10/477012
[patent_app_country] => US
[patent_app_date] => 2002-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12035
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20050013810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477012 | Regulating immune response using dendritic cells | May 7, 2002 | Abandoned |
Array
(
[id] => 6869957
[patent_doc_number] => 20030082646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL'
[patent_app_type] => new
[patent_app_number] => 10/139496
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 36211
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139496 | Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL | May 5, 2002 | Abandoned |
Array
(
[id] => 6870117
[patent_doc_number] => 20030082806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Maturation of antigen-presenting cells using activated T cells'
[patent_app_type] => new
[patent_app_number] => 10/136024
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20729
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136024 | Maturation of antigen-presenting cells using activated T cells | Apr 28, 2002 | Abandoned |
| 10/030151 | Method of obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purpose | Apr 14, 2002 | Abandoned |
Array
(
[id] => 6874506
[patent_doc_number] => 20030194803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance'
[patent_app_type] => new
[patent_app_number] => 10/121909
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23518
[patent_no_of_claims] => 114
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194803.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121909 | Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6656050
[patent_doc_number] => 20030106084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells'
[patent_app_type] => new
[patent_app_number] => 10/119637
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12203
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20030106084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119637 | Methods of blocking tissue destruction by autoreactive T cells | Apr 9, 2002 | Abandoned |
Array
(
[id] => 6715986
[patent_doc_number] => 20030027334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Method for generating immortal dendritic cell lines'
[patent_app_type] => new
[patent_app_number] => 10/121148
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13712
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121148 | Method for generating immortal dendritic cell lines | Apr 9, 2002 | Abandoned |
| 10/009261 | Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy | Apr 3, 2002 | Abandoned |
Array
(
[id] => 6842519
[patent_doc_number] => 20030147866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Novel BGP compounds for therapy and diagnosis and methods for using same'
[patent_app_type] => new
[patent_app_number] => 10/116011
[patent_app_country] => US
[patent_app_date] => 2002-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25337
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116011 | Novel BGP compounds for therapy and diagnosis and methods for using same | Apr 2, 2002 | Abandoned |
Array
(
[id] => 5905011
[patent_doc_number] => 20020141977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Immunotherapy based on dendritic cells'
[patent_app_type] => new
[patent_app_number] => 10/113569
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9207
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20020141977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113569 | Immunotherapy based on dendritic cells | Apr 1, 2002 | Abandoned |
Array
(
[id] => 6656161
[patent_doc_number] => 20030077708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Antigen presenting system and methods for activation of T-cells'
[patent_app_type] => new
[patent_app_number] => 10/105678
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27020
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105678 | Antigen presenting system and methods for activation of T-cells | Mar 24, 2002 | Abandoned |
Array
(
[id] => 6813246
[patent_doc_number] => 20030072796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Synthetic antigen presenting matrix with liposome support'
[patent_app_type] => new
[patent_app_number] => 10/105200
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27115
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105200 | Synthetic antigen presenting matrix with liposome support | Mar 24, 2002 | Abandoned |
Array
(
[id] => 6688443
[patent_doc_number] => 20030032168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein'
[patent_app_type] => new
[patent_app_number] => 10/097580
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14063
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032168.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097580 | Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein | Mar 14, 2002 | Abandoned |
Array
(
[id] => 6821275
[patent_doc_number] => 20030219436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein'
[patent_app_type] => new
[patent_app_number] => 10/098221
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6621
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10098221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/098221 | Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion protein | Mar 14, 2002 | Abandoned |
Array
(
[id] => 6745169
[patent_doc_number] => 20030022352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein'
[patent_app_type] => new
[patent_app_number] => 10/097597
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14057
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097597 | Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein | Mar 14, 2002 | Abandoned |
